Detection of FLT3-ITDMutation in Twenty ChildwithAcuteMyeloidLeukemia in One Iraqi Teaching Hospital
Background:Pediatric acute myeloid leukemia (AML) has a poor prognosis, and novel therapies are needed. The FLT3 tyrosine kinase inhibitorsrepresents a promising target in pediatric AML. Objectives:This study was done to estimate the frequency of FLT3- ITD mutation in childhood acute myeloid leukemi...
Main Authors: | Ethar k. Dhahir, Subh S. Al-Mudallel, Maysaa A. Dhahi |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2012-07-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/743 |
Similar Items
-
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-04-01) -
Targeting FLT3 Mutations in Acute Myeloid Leukemia
by: Riad El Fakih, et al.
Published: (2018-01-01) -
Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia
by: Moo-Kon Song, et al.
Published: (2022-10-01) -
15,16-Dihydrotanshinone I inhibits the proliferation of MV4-11 by means of apoptosis via antagonizing FLT3-ITD/STAT5/Mcl-1 pathway
by: Mansheng Luo, et al.
Published: (2023-01-01) -
Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
by: Motoki Eguchi, et al.
Published: (2020-07-01)